Berlin, Germany

Marcus Koppitz

USPTO Granted Patents = 26 

 

 

Average Co-Inventor Count = 8.8

ph-index = 5

Forward Citations = 66(Granted Patents)


Location History:

  • Garching, DE (2000)
  • Berlin, DE (2003 - 2022)

Company Filing History:


Years Active: 2000-2022

Loading Chart...
Loading Chart...
Loading Chart...
26 patents (USPTO):

Title: The Innovative Journey of Marcus Koppitz: Advancements in Pharmaceutical Patents

Introduction: Marcus Koppitz, based in Berlin, Germany, has garnered a notable reputation in the field of pharmaceuticals with an impressive portfolio of 26 patents. His work is characterized by innovative contributions that focus on the development of compounds for various medical applications. Koppitz's inventions showcase a commitment to addressing critical health challenges, particularly in the realm of hyperproliferative and neurogenic diseases.

Latest Patents: Among Koppitz's latest contributions are two significant patents. The first is for his work on 2-(morpholin-4-yl)-1,7-naphthyridine compounds. This invention details methods for preparing these compounds and explores their use in pharmaceutical compositions aimed at treating hyperproliferative diseases. The second patent pertains to pyrazolo-pyrrolo-pyrimidine-dione derivatives functioning as P2X3 inhibitors. This innovation outlines methods of preparation and application of these compounds for treating neurogenic diseases, either independently or alongside other active ingredients.

Career Highlights: Throughout his career, Marcus Koppitz has made substantial contributions while working with Bayer Pharma Aktiengesellschaft and Bayer Intellectual Property GmbH. His role in these esteemed companies has allowed him to refine his expertise in drug development and intellectual property, solidifying his status as a significant contributor in the pharmaceutical sector.

Collaborations: Koppitz's influence in the field is further amplified through his collaborations with notable colleagues, including Gerhard Siemeister and Benjamin Bader. These partnerships underscore the collaborative nature of innovation in pharmaceuticals, highlighting the importance of teamwork in driving forward advancements that can lead to substantial therapeutic benefits.

Conclusion: Marcus Koppitz's journey in the realm of pharmaceuticals exemplifies the essence of innovation and dedication to improving healthcare outcomes. With 26 patents to his name, his inventions reflect a deep understanding of medical challenges and the potential solutions chemical compounds can offer. As he continues to push the boundaries of pharmaceutical innovation, Koppitz remains a pivotal figure in the ongoing quest for effective treatments against various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…